Annaelisa Tasciotti

A Dose-Escalation and Signal-Generating Study of the Immunocytokine L19-IL2 in Combination with Dacarbazine for the Therapy of Patients with Metastatic Melanoma

Thomas Eigentler, Benjamin Weide, Filippo de Braud et al. · Clinical Cancer Research · 2011 · 149 citations · Full text

Phase I/II study of the tumour-targeting human monoclonal antibody–cytokine fusion protein L19-TNF in patients with advanced solid tumours

Gianluca Spitaleri, Rossana Berardi, Chiara Pierantoni et al. · Journal of Cancer Research and Clinical Oncology · 2012 · 100 citations · Full text

Cancer Immunosurveillance, Oncology, Phase I/ii Study +10

Isolated limb perfusion with the tumor‐targeting human monoclonal antibody–cytokine fusion protein L19‐TNF plus melphalan and mild hyperthermia in patients with locally advanced extremity melanoma

Francesco Papadia, Valéria Basso, Roberto Patuzzo et al. · Journal of Surgical Oncology · 2012 · 86 citations

The tumor-targeting immunocytokine F16-IL2 in combination with doxorubicin: dose escalation in patients with advanced solid tumors and expansion into patients with metastatic breast cancer

Chiara Catania, Michela Maur, Rossana Berardi et al. · Cell Adhesion & Migration · 2015 · 62 citations · Full text

Non-typeable Haemophilus influenzae protein vaccine in adults with COPD: A phase 2 clinical trial

Tom Wilkinson, Stuart Schembri, Christopher E. Brightling et al. · Vaccine · 2019 · 52 citations · Full text